FIELD: chemistry.
SUBSTANCE: in formula (Ib) 
R24 is selected from group, consisting of halogen, -CF3, -OCF3, -OR2, C1-6-alkyl-Z- and R6-W1-C1-6alkylene-Z-; L1 is bond, -O-, -S-, -S(O)2-, -C(O)- or -N(R11)-; G1 is C1-6-alkyl, C3-10-cycloalkyl or piperidyl, optionally substituted with one or several substituents, selected from C3-10-cycloalkyl, L2 is -N(R20)-; L3 is -C(O)-; R1 is hydrogen; G2 is 
.
EFFECT: increase of composition and treatment method efficiency.
33 cl, 15 dwg, 480 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AMIDE DERIVATIVES AS GK ACTIVATORS | 2002 |
|
RU2374236C2 |
| MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR | 2011 |
|
RU2576036C2 |
| DERIVATIVES OF UREA, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2296120C2 |
| PRIMARY CARBOXAMIDES AS BTK INHIBITORS | 2014 |
|
RU2708395C2 |
| IMIDAZOLOTHIAZOL DERIVATIVES FOR TREATING DISEASES | 2007 |
|
RU2441011C2 |
| TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATING SKIN DISEASES | 2009 |
|
RU2544011C2 |
| NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME FOR TREATMENT OF INFLAMMATORY DISORDERS | 2014 |
|
RU2675818C2 |
| 2-ARYLPROPIONIC ACIDS AND DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS, CONTAINING THEREOF | 2009 |
|
RU2520212C2 |
| AZETIDINYL DIAMIDES AS MONOACYLGLICEROL LIPASE INHIBITORS | 2010 |
|
RU2569298C2 |
| PROLYL HYDROXYLASE INHIBITORS AND APPLICATION METHODS THEREOF | 2007 |
|
RU2429226C9 |
